NCT05307627View on ClinicalTrials.gov

The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

WithdrawnOBSERVATIONAL

0

Timeline

Start Date

March 14, 2022

Primary Completion Date

December 14, 2023

Study Completion Date

December 14, 2023

Conditions

Aging

Interventions

DRUG

low-dose naltrexone

LDN doses \<20 mg/day

Trial Locations (1)

48104

AgelessRx, Ann Arbor

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AgelessRx

INDUSTRY

NCT05307627 - The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging | Biotech Hunter | Biotech Hunter